178 related articles for article (PubMed ID: 33668452)
1. Hydrazones of 4-(Trifluoromethyl)benzohydrazide as New Inhibitors of Acetyl- and Butyrylcholinesterase.
Krátký M; Svrčková K; Vu QA; Štěpánková Š; Vinšová J
Molecules; 2021 Feb; 26(4):. PubMed ID: 33668452
[TBL] [Abstract][Full Text] [Related]
2. Novel Iodinated Hydrazide-hydrazones and their Analogues as Acetyl- and Butyrylcholinesterase Inhibitors.
Krátký M; Štěpánková Š; Brablíková M; Svrčková K; Švarcová M; Vinšová J
Curr Top Med Chem; 2020; 20(23):2106-2117. PubMed ID: 32814531
[TBL] [Abstract][Full Text] [Related]
3.
Krátký M; Baranyai Z; Štěpánková Š; Svrčková K; Švarcová M; Stolaříková J; Horváth L; Bősze S; Vinšová J
Molecules; 2020 May; 25(10):. PubMed ID: 32408517
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Biological Evaluation and Molecular Docking Study of Hydrazone-Containing Pyridinium Salts as Cholinesterase Inhibitors.
Parlar S; Bayraktar G; Tarikogullari AH; Alptüzün V; Erciyas E
Chem Pharm Bull (Tokyo); 2016; 64(9):1281-7. PubMed ID: 27581632
[TBL] [Abstract][Full Text] [Related]
5. 2-Hydroxy-
Krátký M; Štěpánková Š; Houngbedji NH; Vosátka R; Vorčáková K; Vinšová J
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31694272
[TBL] [Abstract][Full Text] [Related]
6. N-[3,5-Bis(trifluoromethyl)phenyl]-5-bromo-2-hydroxybenzamide Analogues: Novel Acetyl- and Butyrylcholinesterase Inhibitors.
Krátký M; Jaklová K; Štěpánková Š; Svrčková K; Pflégr V; Vinšová J
Curr Top Med Chem; 2020; 20(23):2094-2105. PubMed ID: 32814530
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
Utku S; Gökçe M; Orhan I; Sahin MF
Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
[TBL] [Abstract][Full Text] [Related]
8. 1,4-Substituted 4-(1H)-pyridylene-hydrazone-type inhibitors of AChE, BuChE, and amyloid-β aggregation crossing the blood-brain barrier.
Prinz M; Parlar S; Bayraktar G; Alptüzün V; Erciyas E; Fallarero A; Karlsson D; Vuorela P; Burek M; Förster C; Turunc E; Armagan G; Yalcin A; Schiller C; Leuner K; Krug M; Sotriffer CA; Holzgrabe U
Eur J Pharm Sci; 2013 Jul; 49(4):603-13. PubMed ID: 23643737
[TBL] [Abstract][Full Text] [Related]
9. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a series of dithiocarbamates as new cholinesterase inhibitors.
Altıntop MD; Gurkan-Alp AS; Ozkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2013 Aug; 346(8):571-6. PubMed ID: 23881696
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evolution of hydrazones derived from 4-(trifluoromethyl)benzohydrazide.
Krátký M; Bősze S; Baranyai Z; Stolaříková J; Vinšová J
Bioorg Med Chem Lett; 2017 Dec; 27(23):5185-5189. PubMed ID: 29097168
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, in silico and in vitro studies of hydrazide-hydrazone imine derivatives as potential cholinesterase inhibitors.
Güngör SA
Chem Biol Drug Des; 2023 Oct; 102(4):676-691. PubMed ID: 37258044
[TBL] [Abstract][Full Text] [Related]
14. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alptuzun V; Erciyas E; Holzgrabe U
Bioorg Chem; 2019 Jun; 87():888-900. PubMed ID: 30538051
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory potential of hydrazide based Schiff bases.
Rahim F; Ullah H; Taha M; Wadood A; Javed MT; Rehman W; Nawaz M; Ashraf M; Ali M; Sajid M; Ali F; Khan MN; Khan KM
Bioorg Chem; 2016 Oct; 68():30-40. PubMed ID: 27441832
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular modelling of thiadizole based hydrazone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitory activities.
Işık A; Acar Çevik U; Karayel A; Celik I; Erçetin T; Koçak A; Özkay Y; Kaplancıklı ZA
SAR QSAR Environ Res; 2022 Mar; 33(3):193-214. PubMed ID: 35243936
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
20. Novel arylcarbamate-N-acylhydrazones derivatives as promising BuChE inhibitors: Design, synthesis, molecular modeling and biological evaluation.
Yamazaki DAS; Rozada AMF; Baréa P; Reis EC; Basso EA; Sarragiotto MH; Seixas FAV; Gauze GF
Bioorg Med Chem; 2021 Feb; 32():115991. PubMed ID: 33440318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
